EMvision Research Notes, page-2

Great work dazdog.

RAP had a market cap of $300 mil plus because they had successful Australian trials and there was great expectations that the USA trials would be equally successful - but not to be - yet. RAP was possibly 2 years ahead of EMV at the USA trial stage.

Also RAP is an algorithim. No hardware.
Massive markets to disrupt and basically no marketing costs. 95% plus gross profit margins. It just plugs straight into a telehealth providers platform.

I agree EMV has a massive market to also disrupt.
But it does involve hardware and will involve sales and marketing and training. The big advantage EMV has over RAP which is not a proper comparitive IMO is the quality of management. RAP is sorely lacking in this department with many rookie mistakes to the cost of shareholders.

Both are great innovations from Qld uni.